Markets Gone Wild

ZyVersa Therapeutics Developing Cholesterol Transport Mediator for Kidney Diseases ZyVersa Therapeutics’ Breakthrough Treatment for Glomerular Diseases Cholesterol Transport Mediator™ VAR 200 is currently in development by ZyVersa Therapeutics to target and reduce renal cholesterol and lipid accumulation that damages the kidneys’ filtration system in patients with glomerular diseases. These diseases include diabetic kidney disease, focal…

Investors Withdraw Funds from Binance Amid SEC Lawsuit SEC Allegations Against Binance Investors are pulling out their funds from Binance following the US securities regulator’s lawsuit against the top cryptocurrency exchange for alleged multiple violations of federal securities laws. The Securities and Exchange Commission (SEC) in a complaint filed on Monday accused Binance of operating…

Fennec Pharmaceuticals Announces Approval for Pedmarqsi™ in the European Union New Therapy for Reducing Cisplatin-induced Hearing Loss in Pediatric Patients Research Triangle Park, N.C., June 06, 2023 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX) has recently made a groundbreaking announcement regarding their latest development in pediatric oncology treatment. The company has introduced…

Bridge Mode: Revolutionizing Network Connectivity As technology continues to rapidly evolve, the need for faster and more cost-effective network solutions has never been more pressing. In a groundbreaking move, Cloudbrink has introduced the industry’s first software-only solution that replaces traditional hardware appliances like VPN and SD-WAN for power users in the hybrid workplace. The Era…

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform: Consolidating and Coordinating IP Assets A global medical technology company has recently chosen Anaqua’s AQX to help consolidate and coordinate the management of all its intellectual property assets. This announcement was made in Boston on June 6, 2023. Anaqua, a leader in innovation and IP…

Welcome to the Future of Antibody Discovery with Telesis Bio Inc. Streamlining Antibody Discovery Workflows Welcome to the world of tomorrow, where Telesis Bio Inc. is revolutionizing the field of molecular biology with their cutting-edge automated workflow solutions. Say goodbye to tedious manual processes and hello to a seamless, efficient approach to antibody discovery and…

Welcome to the Future: 5G Service Market Explained The Skinny on 5G So, you’ve probably heard the buzz about 5G service – the next big thing in wireless technology that promises faster speeds, greater reliability, and enhanced security. Sounds pretty snazzy, right? Well, you’re not alone in your excitement. According to a recent research report,…